Literature DB >> 15372089

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity.

Urs A Meyer1.   

Abstract

Physicians have long been aware of the subtle differences in the responses of patients to medication. The recognition that a part of this variation is inherited, and therefore predictable, created the field of pharmacogenetics fifty years ago. Knowing the gene variants that cause differences among patients has the potential to allow 'personalized' drug therapy and to avoid therapeutic failure and serious side effects.

Entities:  

Mesh:

Year:  2004        PMID: 15372089     DOI: 10.1038/nrg1428

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  78 in total

1.  SNP calling using genotype model selection on high-throughput sequencing data.

Authors:  Na You; Gabriel Murillo; Xiaoquan Su; Xiaowei Zeng; Jian Xu; Kang Ning; Shoudong Zhang; Jiankang Zhu; Xinping Cui
Journal:  Bioinformatics       Date:  2012-01-16       Impact factor: 6.937

Review 2.  Genome-wide association studies in pharmacogenomics.

Authors:  Ann K Daly
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

Review 3.  Patient profiling for treatment toxicity: potential use of clinical and genomic factors.

Authors:  Terri S Armstrong; Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

Review 4.  CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.

Authors:  Jonas A de Souza; Olufunmilayo I Olopade
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

Review 5.  Pharmacogenomics: challenges and opportunities.

Authors:  Dan M Roden; Russ B Altman; Neal L Benowitz; David A Flockhart; Kathleen M Giacomini; Julie A Johnson; Ronald M Krauss; Howard L McLeod; Mark J Ratain; Mary V Relling; Huijun Z Ring; Alan R Shuldiner; Richard M Weinshilboum; Scott T Weiss
Journal:  Ann Intern Med       Date:  2006-11-21       Impact factor: 25.391

6.  Personalized drug therapy; the genome, the chip and the physician.

Authors:  Lionel D Lewis
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

Review 7.  Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy.

Authors:  Magnus Ingelman-Sundberg; Cristina Rodriguez-Antona
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 8.  Pharmacogenomics and therapeutic prospects in dementia.

Authors:  Ramón Cacabelos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

Review 9.  Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Authors:  Roxana Daneshjou; Rachel Huddart; Teri E Klein; Russ B Altman
Journal:  Semin Cutan Med Surg       Date:  2019-03-01

Review 10.  Pharmacogenetics and pharmacogenomics of anticancer agents.

Authors:  R Stephanie Huang; Mark J Ratain
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.